EFEMP1 and breast angiosarcoma: In 2018, Chen et al. presented the first evidence indicating that the EFEMP1 (EGF-containing fibulin-like extracellular matrix protein 1) gene may be a potential gene in BA susceptibility as based on a cohort study including 343 BA cases and 1,716 healthy controls.